CEG vs PFE: Which Is the Better Buy?
Side-by-side comparison of Constellation Energy Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Constellation Energy Corporation · Utilities
$265.12
+11.3% upside to fair value
Med Conviction
Grade B-
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
CEG has more upside to fair value
(+11.3%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CEG |
PFE |
| Current Price |
$265.12 |
$25.22 |
| Fair Value Estimate |
$295.00 |
$25.92 |
| Upside to Fair Value |
+11.3%
|
+2.8%
|
| Market Cap |
$95.2B |
$143.7B |
| Forward P/E |
22.6x
|
19.2x
|
| EV / EBITDA |
12.6x
|
12.3x
|
| Price / Sales |
2.9x
|
2.3x
|
| Price / FCF |
196.2x
|
15.2x
|
| Revenue Growth YoY |
+35.3%
|
+5.4%
|
| Gross Margin |
44.6%
|
69.3%
|
| Operating Margin |
14.6%
|
23.4%
|
| Return on Equity |
11.1%
|
8.4%
|
| Dividend Yield |
0.64% |
0% |
| FCF Yield |
0.51%
|
6.6%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Constellation Energy is the largest private-sector power producer in the world and the largest operator of nuclear plants in the United States, controlling roughly 32,400 megawatts of largely carbon-free generation before its January 2026 acquisition of Calpine added about 23 gigawatts of natural gas and geothermal capacity to create a nearly 60 gigawatt platform spanning nuclear, gas, wind, sola…
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
| Metric |
CEG |
PFE |
| Zone Low |
$221.00 |
$19.44 |
| Zone High |
$251.00 |
$22.03 |
| In Buy Zone? |
No
|
No
|